WallStreetZenWallStreetZen

NASDAQ: ESLA
Estrella Immunopharma Inc Stock Ownership - Who owns Estrella Immunopharma?

Insider buying vs selling

Have Estrella Immunopharma Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Owl Creek Asset Management LP10% Owner2023-09-29255,000$10.86
$2.77MSell

1 of 1

ESLA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ESLA insiders and whales buy or sell their stock.

ESLA Shareholders

What type of owners hold Estrella Immunopharma Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Eureka Therapeutics Inc69.04%25,277,831$27.05MInsider
Jianwei Li6.55%2,399,490$2.57MInsider
Tradeup Acquisition Sponsor LLC3.13%1,145,760$1.23MInsider
Cheng Liu0.81%297,437$318.26kInsider
Jiandong Xu0.72%264,388$282.90kInsider
Geode Capital Management LLC0.15%56,215$60.15kInstitution
Atw Spac Management LLC0.11%40,000$42.80kInstitution
Hunting Hill Global Capital LLC0.06%21,358$22.85kInstitution
Maso Capital Partners Ltd0.03%10,000$10.70kInstitution
Weston Twigg0.03%10,000$10.70kInsider

1 of 2

ESLA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ESLA0.35%80.34%Net Selling
ICCC13.45%24.31%Net Buying
PMN17.66%24.49%
MTNB11.76%13.73%
CTCX11.98%59.11%Net Buying

Estrella Immunopharma Stock Ownership FAQ

Who owns Estrella Immunopharma?

Estrella Immunopharma (NASDAQ: ESLA) is owned by 0.35% institutional shareholders, 80.34% Estrella Immunopharma insiders, and 19.30% retail investors. Eureka Therapeutics Inc is the largest individual Estrella Immunopharma shareholder, owning 25.28M shares representing 69.04% of the company. Eureka Therapeutics Inc's Estrella Immunopharma shares are currently valued at $26.92M.

If you're new to stock investing, here's how to buy Estrella Immunopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.